Second-generation antipsychotics - a panacea?

Simple item page
dc.contributor.authorCarey, Paul D.en_ZA
dc.contributor.authorStein, Danen_ZA
dc.contributor.authorEmsley, Robinen_ZA
dc.date.accessioned2013-01-23T14:11:29Z
dc.date.available2013-01-23T14:11:29Z
dc.date.issued2004
dc.descriptionCITATION: Carey, P. D., Stein, D. & Emsley, R. 2004. Second-generation antipsychotics - a panacea? South African Journal of Psychiatry, 10(4):a121, doi:10.4102/sajpsychiatry.v10i4.121.
dc.descriptionThe original publication is available at https://sajp.org.za
dc.description.abstractThe introduction of the second-generation antipsychotics (SGAs) (atypical antipsychotics) for the treatment of psychotic disorders has changed the goals of modern therapeutic outcomes. No longer are positive symptoms of psychosis in schizophrenia the only outcomes measured, but dimensions including negative and cognitive symptoms are now crucial to determining efficacy. As a result outcomes in these areas are increasingly impacting on our choice of treatment.
dc.description.urihttps://sajp.org.za/index.php/sajp/article/view/121
dc.description.versionPublisher's version
dc.format.extent3 pages
dc.identifier.citationCarey, P. D., Stein, D. & Emsley, R. 2004. Second-generation antipsychotics - a panacea? South African Journal of Psychiatry, 10(4):a121, doi:10.4102/sajpsychiatry.v10i4.121.
dc.identifier.issn2078-6786 (online)
dc.identifier.urihttp://hdl.handle.net/10019.1/79031
dc.language.isoen
dc.publisherAOSIS
dc.rights.holderAuthors retain copyright
dc.subject.otherAntipsychoticsen_ZA
dc.titleSecond-generation antipsychotics - a panacea?en_ZA
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
carey_second_2004.pdf
Size:
126.74 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
Collections
Research Articles (Psychiatry)